Wilmington, Delaware--(Newsfile Corp. - March 25, 2024) - Rigrodsky Law, P.A. is investigating Landos Biopharma, Inc. ("Landos") (NASDAQ: LABP) regarding possible breaches of fiduciary duties and other violations of law related to Landos's agreement to be acquired by AbbVie Inc. Under the terms of the agreement, Landos shareholders will receive $20.42 per share in cash upon closing, plus one non-tradable contingent value right per share with a value of up to $11.14 per share, subject to the achievement of a clinical development milestone.
To learn more about this investigation and your rights, visit: .
To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: info@rl-legal.com